Syncom Healthcare Limited engages in the manufacture and marketing of pharmaceutical formulations in India and internationally. It also offers nutraceutical products and ayurvedic formulations. The company was incorporated in 2002 and is based in Indore, India. Syncom Healthcare Limited is in corporate insolvency resolution process under the provisions of Section 7 of the Insolvency and Bankruptcy Code, 2016.
Research context
Syncom Healthcare Limited appears in PyInvesting’s India Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- INR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Syncom Healthcare Limited is currently in a long term uptrend where the price is trading 58.3% above its 200 day moving average.
From a valuation standpoint, the stock is 47.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
Syncom Healthcare Limited's total revenue sank by 52.8% to $5M since the same quarter in the previous year.
Its net income has dropped by 2.0% to $-13M since the same quarter in the previous year.
Finally, its free cash flow grew by 3528.6% to $30M since the same quarter in the previous year.
Based on the above factors, Syncom Healthcare Limited gets an overall score of 3/5.